These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2655682)

  • 21. Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR).
    Stevens RE; Limsakun T; Evans G; Mason DH
    J Pharm Sci; 1998 Dec; 87(12):1531-4. PubMed ID: 10189261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
    Kaski M; Heinonen E; Sivenius J; Tuominen J; Anttila M
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():231-9. PubMed ID: 1920391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.
    Macphee GJ; McPhail EM; Butler E; Brodie MJ
    Eur J Clin Pharmacol; 1986; 31(2):195-9. PubMed ID: 3803416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
    Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
    Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy.
    Bonneton J; Iliadis A; Genton P; Dravet C; Viallat D; Mesdjian E
    Epilepsy Res; 1993 Mar; 14(3):257-63. PubMed ID: 8504796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluctuations of carbamazepine concentrations during the day for two slow-release preparations.
    May T; Rambeck B
    Ther Drug Monit; 1989; 11(1):21-4. PubMed ID: 2911848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I; Chamberlin N
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine (CBZ) controlled release compared with conventional CBZ: a controlled study of attention and vigilance in children with epilepsy.
    Pieters MS; Jennekens-Schinkel A; Stijnen T; Edelbroek PM; Brouwer OF; Liauw L; Heyer A; Lanser JB; Peters AC
    Epilepsia; 1992; 33(6):1137-44. PubMed ID: 1464276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function.
    van der Meyden CH; Bartel PR; Sommers DK; Blom M; Becker P; Erasmus S; Griesel D
    Epilepsia; 1992; 33(2):335-42. PubMed ID: 1547763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of carbamazepine on psychomotor performance in näive subjects.
    MacPhee GJ; Goldie C; Roulston D; Potter L; Agnew E; Laidlaw J; Brodie MJ
    Eur J Clin Pharmacol; 1986; 30(1):37-42. PubMed ID: 3709630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
    Persson LI; Ben-Menachem E; Bengtsson E; Heinonen E
    Epilepsy Res; 1990 Jul; 6(2):134-40. PubMed ID: 2201541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine.
    Barakat NS; Elbagory IM; Almurshedi AS
    AAPS PharmSciTech; 2008; 9(3):931-8. PubMed ID: 18686038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine.
    Dhalla Z; Bruni J; Sutton J
    Can J Neurol Sci; 1991 Feb; 18(1):66-8. PubMed ID: 2036618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.
    Wilding IR; Davis SS; Hardy JG; Robertson CS; John VA; Powell ML; Leal M; Lloyd P; Walker SM
    Br J Clin Pharmacol; 1991 Nov; 32(5):573-9. PubMed ID: 1954073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine.
    Malminiemi K; Keränen T; Kerttula T; Moilanen E; Ylitalo P
    Int J Clin Pharmacol Ther; 2000 Nov; 38(11):540-5. PubMed ID: 11097146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
    Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
    Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.